Join the COVID-19 group to help and get support from people like you.
COVID-19 News (Page 5)
Related terms: 2019-nCoV, 2019 Novel Coronavirus, Coronavirus, SARS-CoV-2 Infection, Novel Coronavirus Pneumonia
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
WEDNESDAY, Jan. 8, 2025 – Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series...
Despite Previous Data, Paxlovid May Be Useful for Long Covid After All
WEDNESDAY, Jan. 8, 2024 – The antiviral pill Paxlovid might help some patients who are suffering from long COVID. A five-day course of Paxlovid is known to help limit symptoms and shorten illness in...
Accelerated Kidney Function Decline Seen With COVID-19 Versus Pneumonia
MONDAY, Dec. 30, 2024 – COVID-19 is associated with accelerated decline in kidney function, especially after hospitalization, according to a study published online Dec. 26 in JAMA Network Open....
Reporting of Human Adenoviruses Has Declined Since COVID-19
FRIDAY, Dec. 27, 2024 – Reporting of human adenovirus (HAdV) types decreased since the COVID-19 pandemic, according to research published in the Dec. 19 issue of the U.S. Centers for Disease Control...
Brief Outpatient Rehab Program Beneficial for Post-COVID-19 Condition
THURSDAY, Dec. 26, 2024 – A brief outpatient rehabilitation program with a cognitive and behavioral approach is effective and safe for patients with post-COVID-19 condition (PCC), according to a...
Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023
THURSDAY, Dec. 26, 2024 – The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research letter published online Dec. 13 in JAMA Network Open....
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
THURSDAY, Dec. 26, 2024 – COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability, according to a study published online Dec. 23 in...
Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19
THURSDAY, Dec. 26, 2024 – For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-day mortality,...
1 in 5 Adults With Long Covid Struggle With Daily Activities
THURSDAY, Dec. 19, 2024 – Millions of American adults are struggling with Long COVID, and a fifth have symptoms so debilitating they interfere with daily activities, a new report finds. "Frequently...
Long COVID Is Taking Toll on Americans' Finances
MONDAY, Dec. 9, 2024 – Long COVID is placing a financial strain on many Americans, a new study reports. People with Long COVID have a harder time paying their bills, buying groceries and maintaining...
Most Young People With Long COVID Recover Within 2 Years
THURSDAY, Dec. 5, 2024 – Most children and teenagers can shake long COVID within a couple of a years, a new, reassuring study finds. About 70% of children and teens diagnosed with long COVID recover...
Cognitive Behavioral Therapy Aids Patients With Long COVID
MONDAY, Dec. 2, 2024 – Cognitive behavioral therapy (CBT) and physical and mental health rehabilitation can help improve symptoms of long COVID, according to a review published online Nov. 27 in The...
When's Best Time for Your COVID Booster? That May Depend on You
MONDAY, Dec. 2, 2024 – Folks might want to try timing their COVID-19 booster vaccine to coincide with a period of increased transmission in their area, a new study suggests. Doing so can improve...
Nerve Stimulation Device Might Ease Long COVID Symptoms
FRIDAY, Nov. 29, 2024 – A painless nerve-zapping device called Transcutaneous Electrical Nerve Stimulation (TENS) has long been used to ease arthritis, back pain and other ailments. Now, researchers...
Trump Picks Vaccine Mandate Critic Dr. Jay Bhattacharya to Head National Institutes of Health
WEDNESDAY, Nov. 27, 2024 – President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation's...